MarketCap
Facebook
X
TelegramHill-Rom Holdings, Inc. Total Assets 2011-2026 | HRC
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets Hill-Rom Holdings, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 4.67 B | 4.92 B | 4.36 B | 4.53 B | 4.26 B | 4.46 B | 1.75 B | 1.59 B | 1.63 B | 1.3 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.92 B | 1.3 B | 3.35 B |
Total Assets of other stocks in the Medical instruments industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
261 K | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
25.8 B | $ 19.93 | 0.99 % | $ 10.2 B | USA |
 |
Luminex Corporation
LMNX
|
825 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
10.9 M | - | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
213 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
2.07 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
192 M | - | - | $ 282 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
4.46 B | - | -0.02 % | $ 16.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
26.7 M | $ 8.71 | 3.75 % | $ 176 M | USA |
 |
Alcon
ALC
|
30.3 B | $ 81.19 | 0.07 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
609 M | $ 36.37 | -1.57 % | $ 1.71 B | USA |
 |
Repro Med Systems
KRMD
|
28.5 M | $ 5.37 | -1.56 % | $ 245 M | USA |
 |
Haemonetics Corporation
HAE
|
2.45 B | $ 65.87 | -0.15 % | $ 3.32 B | USA |
 |
electroCore
ECOR
|
16.1 M | $ 6.83 | -3.73 % | $ 37.7 K | USA |
 |
AngioDynamics
ANGO
|
280 M | $ 10.2 | 2.2 % | $ 417 M | USA |
 |
ICU Medical
ICUI
|
4.2 B | $ 149.04 | -0.66 % | $ 3.63 B | USA |
 |
InfuSystem Holdings
INFU
|
99.4 M | $ 8.14 | 1.12 % | $ 168 M | USA |
 |
The Cooper Companies
COO
|
12.4 B | $ 80.95 | 0.72 % | $ 16.1 B | USA |
 |
Masimo Corporation
MASI
|
2.63 B | $ 134.5 | -1.29 % | $ 7.17 B | USA |
 |
Harvard Bioscience
HBIO
|
137 M | $ 0.5 | -7.06 % | $ 21.2 M | USA |
 |
Glaukos Corporation
GKOS
|
940 M | $ 117.26 | -1.43 % | $ 5.68 B | USA |
 |
Merit Medical Systems
MMSI
|
2.42 B | $ 80.09 | -0.19 % | $ 4.66 B | USA |
 |
OraSure Technologies
OSUR
|
480 M | $ 2.78 | -0.54 % | $ 207 M | USA |
 |
Isoray
ISR
|
341 M | - | 0.03 % | $ 108 M | USA |
 |
iRhythm Technologies
IRTC
|
931 M | $ 150.09 | 0.74 % | $ 4.68 B | USA |
 |
LeMaitre Vascular
LMAT
|
552 M | $ 84.08 | 0.26 % | $ 1.89 B | USA |
 |
Intuitive Surgical
ISRG
|
18.7 B | $ 505.88 | -0.33 % | $ 180 B | USA |
 |
STERIS plc
STE
|
10.1 B | $ 261.25 | -0.23 % | $ 25.8 B | USA |
 |
NeuroMetrix
NURO
|
15.3 M | - | 5.05 % | $ 9.02 M | USA |
 |
Microbot Medical
MBOT
|
8.33 M | $ 1.84 | -1.34 % | $ 18.8 M |  Israel |
 |
Nephros
NEPH
|
11.9 M | $ 4.4 | 0.23 % | $ 45.7 M | USA |
 |
Utah Medical Products
UTMD
|
135 M | $ 60.16 | -2.42 % | $ 218 M | USA |
 |
Milestone Scientific
MLSS
|
9.8 M | $ 0.29 | -0.7 % | $ 23.1 M | USA |
 |
Envista Holdings Corporation
NVST
|
5.35 B | $ 23.07 | -1.28 % | $ 3.97 B | USA |
 |
Pro-Dex
PDEX
|
61.2 M | $ 38.84 | -1.43 % | $ 128 M | USA |
 |
Predictive Oncology
POAI
|
4.97 M | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
59.2 M | $ 13.69 | 0.48 % | $ 658 M | USA |
 |
Becton, Dickinson and Company
BDX
|
55.3 B | $ 201.67 | 0.29 % | $ 58 B | USA |
 |
Repligen Corporation
RGEN
|
2.83 B | $ 151.86 | -2.88 % | $ 8.46 M | USA |
 |
ResMed
RMD
|
5.1 B | $ 251.52 | -2.37 % | $ 36.7 B | USA |
 |
BioLife Solutions
BLFS
|
399 M | $ 22.08 | -2.21 % | $ 1.02 B | USA |
 |
Stereotaxis
STXS
|
41.9 M | $ 2.26 | -3.21 % | $ 182 M | USA |
 |
Retractable Technologies
RVP
|
161 M | $ 0.69 | 0.16 % | $ 20.7 M | USA |
 |
STAAR Surgical Company
STAA
|
510 M | $ 18.79 | -0.8 % | $ 923 M | USA |
 |
Teleflex Incorporated
TFX
|
7.1 B | $ 105.0 | -0.43 % | $ 4.92 B | USA |
 |
West Pharmaceutical Services
WST
|
3.64 B | $ 226.43 | -2.61 % | $ 16.5 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
5.75 B | $ 12.28 | 0.04 % | $ 2.5 B | USA |